M MELT PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, June 18, 2020, a trademark application was filed for M MELT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the M MELT PHARMACEUTICALS trademark a serial number of 90009224. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2024. This trademark is owned by MELT PHARMACEUTICALS, INC.. The M MELT PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation
m melt pharmaceuticals

General Information

Serial Number90009224
Word MarkM MELT PHARMACEUTICALS
Filing DateThursday, June 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 18, 2021

Trademark Statements

Description of MarkThe mark consists of a stylized "M" in inverse typeface formed within a plurality of green and blue dots arranged to form an irregular octagon, which is shown to the left of the term "MELT" in blue with the term "PHARMACEUTICALS" in green positioned below and offset to the right of the term "MELT" so that the term "PHARMACEUTICALS" begins below the center of the "M" of "MELT".
Goods and ServicesPharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation
Indication of Colors claimedThe colors green and blue are claimed as a feature of the mark.
NOT AVAILABLE"MELT PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMELT PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameMELT PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Thursday, July 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 22, 2020NEW APPLICATION ENTERED
Friday, July 17, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 17, 2020ASSIGNED TO EXAMINER
Friday, September 18, 2020NON-FINAL ACTION WRITTEN
Friday, September 18, 2020NON-FINAL ACTION E-MAILED
Friday, September 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 6, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, April 8, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, April 9, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, April 9, 2021EXAMINERS AMENDMENT E-MAILED
Friday, April 9, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 9, 2021EXAMINER'S AMENDMENT ENTERED
Friday, April 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 18, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 18, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 12, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 12, 2022SOU EXTENSION 1 FILED
Wednesday, January 12, 2022SOU EXTENSION 1 GRANTED
Wednesday, January 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 7, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, February 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 7, 2022SOU EXTENSION 2 FILED
Thursday, July 7, 2022SOU EXTENSION 2 GRANTED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 11, 2023SOU EXTENSION 3 FILED
Wednesday, January 11, 2023SOU EXTENSION 3 GRANTED
Friday, January 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 27, 2023SOU EXTENSION 4 FILED
Tuesday, June 27, 2023SOU EXTENSION 4 GRANTED
Thursday, June 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 8, 2023SOU EXTENSION 5 FILED
Friday, December 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 22, 2023SOU EXTENSION 5 GRANTED
Monday, August 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 19, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Saturday, December 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

pharmaceuticals melt surgical procedure conscious sedation after during compositions administration prior pharmaceutical